• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比利斯提克:一种低成本的即时检测系统,用于测量总血浆胆红素。

Bilistick: a low-cost point-of-care system to measure total plasma bilirubin.

机构信息

Liver Research Centre, Italian Liver Foundation, Trieste, Italy.

出版信息

Neonatology. 2013;103(3):177-81. doi: 10.1159/000345425. Epub 2012 Dec 22.

DOI:10.1159/000345425
PMID:23295342
Abstract

BACKGROUND

Severe neonatal hyperbilirubinemia, with consequent encephalopathy, remains a common cause of morbidity and death in many regions of the world. Poor access to clinical laboratory resources and screening programs to measure plasma bilirubin levels is a major contributor to delayed treatment in developing countries, and the cost of existing point-of-care screening instruments precludes their dissemination.

OBJECTIVES

We are evaluating the accuracy of a low-cost, minimally invasive point-of-care system (Bilistick) requiring a 25-µl blood sample that could be used in low-resource environments to evaluate patients with neonatal jaundice.

METHODS

We compared plasma bilirubin levels in divided blood samples by clinical laboratories and by Bilistick at two medical centers serving term and near-term newborns from ethnically different populations.

RESULTS

118 neonates with bilirubin levels ranging from 24.8 to 501.0 µmol/l were analyzed. The mean bilirubin concentration (±SD) was 215.6 ± 85.5 µmol/l for Bilistick and 226.1 ± 86.4 µmol/l by laboratory determination. Pearson's correlation coefficient between all paired results was 0.961, and the Bland-Altman analysis showed a mean difference of 10.3 µmol/l with a 95% interval of agreement of -38.0 to 58.7 µmol/l.

CONCLUSION

Bilistick is a minimally invasive method for measuring total bilirubin concentration over a wide range of values and should provide an affordable and accurate system for pre-discharge and follow-up screening of jaundiced infants, particularly in low-resource environments.

摘要

背景

严重的新生儿高胆红素血症,进而导致脑病,在世界许多地区仍是发病率和死亡率的一个常见原因。在发展中国家,由于临床实验室资源和血浆胆红素水平筛查方案获取不足,导致治疗延迟,而现有的即时检测筛查仪器费用昂贵,也阻碍了其推广。

目的

我们正在评估一种低成本、微创的即时检测系统(Bilistick)的准确性,该系统需要 25μl 的血样,可在资源匮乏的环境中用于评估患有新生儿黄疸的患者。

方法

我们比较了在为不同种族人群提供足月和近足月新生儿服务的两个医疗中心,由临床实验室和 Bilistick 检测的等分血样的血浆胆红素水平。

结果

共分析了 118 例胆红素水平在 24.8 至 501.0μmol/l 之间的新生儿。Bilistick 检测的胆红素平均浓度(±SD)为 215.6±85.5μmol/l,实验室检测为 226.1±86.4μmol/l。所有配对结果的 Pearson 相关系数为 0.961,Bland-Altman 分析显示平均差值为 10.3μmol/l,95%一致性区间为-38.0 至 58.7μmol/l。

结论

Bilistick 是一种微创方法,可测量宽范围胆红素浓度,应为在资源匮乏环境中,用于经皮黄疸仪筛查后出院前和随访时筛查黄疸婴儿提供一种经济、准确的系统。

相似文献

1
Bilistick: a low-cost point-of-care system to measure total plasma bilirubin.比利斯提克:一种低成本的即时检测系统,用于测量总血浆胆红素。
Neonatology. 2013;103(3):177-81. doi: 10.1159/000345425. Epub 2012 Dec 22.
2
Accuracy of Bilistick (a Point-of-Care Device) to Detect Neonatal Hyperbilirubinemia.Blistick(一种即时检测设备)检测新生儿高胆红素血症的准确性。
J Trop Pediatr. 2020 Dec 1;66(6):630-636. doi: 10.1093/tropej/fmaa026.
3
The point-of-care Bilistick method has very short turn-around-time and high accuracy at lower cutoff levels to predict laboratory-measured TSB.床边 Bilistick 检测法在低值时具有极短的检测周转时间和很高的准确性,可预测实验室检测的 TSB。
Pediatr Res. 2019 Aug;86(2):216-220. doi: 10.1038/s41390-019-0304-0. Epub 2019 Jan 23.
4
Determination of total bilirubin in whole blood from neonates: results from a French multicenter study.新生儿全血总胆红素的测定:一项法国多中心研究的结果。
Clin Chem Lab Med. 2006;44(9):1103-10. doi: 10.1515/CCLM.2006.202.
5
Comparison between Bilistick System and transcutaneous bilirubin in assessing total bilirubin serum concentration in jaundiced newborns.在评估黄疸新生儿血清总胆红素浓度方面,Bilistick系统与经皮胆红素测定法的比较。
J Perinatol. 2017 Sep;37(9):1028-1031. doi: 10.1038/jp.2017.94. Epub 2017 Jun 15.
6
Evaluation of a new transcutaneous bilirubinometer in Chinese newborns.一种新型经皮胆红素仪在中国新生儿中的评估。
Arch Dis Child Fetal Neonatal Ed. 2006 Nov;91(6):F434-8. doi: 10.1136/adc.2005.090217. Epub 2006 Jul 18.
7
Bilirubin measurement for neonates: comparison of 9 frequently used methods.新生儿胆红素测量:9种常用方法的比较
Pediatrics. 2006 Apr;117(4):1174-83. doi: 10.1542/peds.2005-0590.
8
The value of routine bilirubin screening to detect significant hyperbilirubinemia in Thai healthy term newborns.常规胆红素筛查在检测泰国健康足月儿显著高胆红素血症中的价值。
J Med Assoc Thai. 2007 May;90(5):925-30.
9
The value of Bilicheck as a screening tool for neonatal jaundice in term and near-term babies.Bilicheck作为足月儿和近足月儿新生儿黄疸筛查工具的价值。
Acta Paediatr. 2004 Nov;93(11):1486-90. doi: 10.1080/08035250410033042.
10
Visual screening versus transcutaneous bilirubinometry for predischarge jaundice assessment.用于出院前黄疸评估的视觉筛查与经皮胆红素测定法对比
Acta Paediatr. 2008 Jun;97(6):759-63. doi: 10.1111/j.1651-2227.2008.00807.x.

引用本文的文献

1
Comparative analysis of the quantitative point-of-care CareSTART™ total bilirubin with central laboratory total bilirubin assays in neonatal blood samples.比较分析新生儿血样中即时护理 CareSTART™总胆红素定量检测与中心实验室总胆红素检测的结果。
Medicine (Baltimore). 2024 May 24;103(21):e38267. doi: 10.1097/MD.0000000000038267.
2
Validity of BiliDx as a point-of-care bilirubin measurement device to diagnose and monitor neonatal jaundice at Muhimbili National Hospital, an observational study.BiliDx 作为一种即时检测胆红素设备,在穆希比利国家医院用于诊断和监测新生儿黄疸的有效性:一项观察性研究。
BMC Pediatr. 2024 Feb 13;24(1):114. doi: 10.1186/s12887-024-04565-w.
3
A review of existing neonatal hyperbilirubinemia guidelines in Indonesia.
印度尼西亚现有新生儿高胆红素血症指南综述。
F1000Res. 2023 Nov 13;11:1534. doi: 10.12688/f1000research.110550.2. eCollection 2022.
4
Design and field evaluation of a lateral flow cassette device for point-of-care bilirubin measurement.用于即时检测胆红素测量的侧向流动盒式装置的设计与现场评估。
PLOS Glob Public Health. 2023 Aug 8;3(8):e0002262. doi: 10.1371/journal.pgph.0002262. eCollection 2023.
5
Management challenges in the treatment of severe hyperbilirubinemia in low- and middle-income countries: Encouraging advancements, remaining gaps, and future opportunities.低收入和中等收入国家重症高胆红素血症治疗中的管理挑战:令人鼓舞的进展、尚存的差距及未来机遇
Front Pediatr. 2023 Feb 13;11:1001141. doi: 10.3389/fped.2023.1001141. eCollection 2023.
6
Better assessment of neonatal jaundice at home (BEAT Jaundice @home): protocol for a prospective, multicentre diagnostic study.家庭中新生儿黄疸的更好评估(BEAT Jaundice@home):一项前瞻性、多中心诊断研究方案。
BMJ Open. 2022 Nov 17;12(11):e061897. doi: 10.1136/bmjopen-2022-061897.
7
Development of a mobile phone camera-based transcutaneous bilirubinometer for low-resource settings.用于资源匮乏地区的基于手机摄像头的经皮胆红素仪的研发。
Biomed Opt Express. 2022 Apr 15;13(5):2797-2809. doi: 10.1364/BOE.449625. eCollection 2022 May 1.
8
POCT: An Inherently Ideal Tool in Pediatric Laboratory Medicine.即时检验(POCT):儿科检验医学中一种本质上理想的工具。
EJIFCC. 2021 Jun 29;32(2):145-157. eCollection 2021 Jun.
9
Diagnostic methods for neonatal hyperbilirubinemia: benefits, limitations, requirements, and novel developments.新生儿高胆红素血症的诊断方法:益处、局限性、要求及新进展
Pediatr Res. 2021 Aug;90(2):277-283. doi: 10.1038/s41390-021-01546-y. Epub 2021 May 4.
10
Review of bilirubin neurotoxicity II: preventing and treating acute bilirubin encephalopathy and kernicterus spectrum disorders.胆红素神经毒性综述 II:预防和治疗急性胆红素脑病和核黄疸谱系障碍。
Pediatr Res. 2020 Jan;87(2):332-337. doi: 10.1038/s41390-019-0603-5. Epub 2019 Oct 3.